Bill Ackman Pershing Square Capital Management
Bill Ackman is the founder and CEO of Pershing Square Capital Management, a New York–based hedge fund. He employs an activist investing approach, seeking to influence the management and direction of the publicly traded companies in which he invests. Frequently in the public eye, Ackman has been noted for both high-profile successes and controversies, such as his well-known short position in Herbalife.
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$263M |
| 2 |
Air Products & Chemicals
APD
|
+$224M |
| 3 |
Mondelez International
MDLZ
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 58.15% |
| 2 | Consumer Staples | 20.82% |
| 3 | Materials | 14.01% |
| 4 | Real Estate | 7.02% |
| 5 | Healthcare | 0% |
Similar funds
Bill Ackman's Q1 2017 Portfolio in Review
As of Q1 2017, Bill Ackman held 8 positions worth $5.96B, up 0.8% from $5.91B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Bill Ackman withdrew a net $620M in Q1 2017, closing 1 position and reducing 2 holdings. Its most notable exit was Bausch Health, an estimated $263M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 58% of assets, up from 50% a quarter earlier, followed by Consumer Staples and Materials.
- Bill Ackman's biggest Q1 2017 reduction was Air Products & Chemicals, cutting an estimated $224M.
- Bill Ackman fully exited Bausch Health in Q1 2017, selling an estimated $263M.
- Bill Ackman's ten largest holdings make up 100% of its $5.96B portfolio in Q1 2017.
- Bill Ackman opened 0 new positions and closed 1 in Q1 2017.
- Bill Ackman's portfolio value rose 0.8% quarter-over-quarter to $5.96B.
Based on Pershing Square Capital Management's 13F filing for Q1 2017, filed 15 May 2017.